Last updated 4 days ago
A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.
240 patients around the world
Available in Spain, Brazil, Argentina, United States
Up to 5 years
Sanofi
4Research sites
240Patients around the world
This study is for people with
Graft versus Host Disease
Requirements for the patient
From 12 Years
All Gender
Medical requirements
Sites
CEMIC - Hospital Universitario Sede Saavedra - CABA, Buenos Aires
Recruiting
Hospital Británico de Buenos Aires - CABA
Recruiting
Instituto Médico Especializado Alexander Fleming - CABA, Buenos Aires
Recruiting
Hospital das Clínicas da Faculdade de Medicina da São Paulo - USP
Recruiting
StudyROCKnrol-1
SponsorSanofi
Conditions
Requirements
From 12 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT06143891
